Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Oppenheimer biotech analyst to hold an analyst/industry conference call » 15:23
10/23/20
10/23
15:23
10/23/20
15:23
ALLO

Allogene Therapeutics

$36.00 /

+0.64 (+1.81%)

, AMGN

Amgen

$227.59 /

-0.31 (-0.14%)

, BLUE

Bluebird Bio

$55.37 /

-0.13 (-0.23%)

, BMY

Bristol-Myers

$60.41 /

-0.355 (-0.58%)

, CRSP

Crispr Therapeutics

$91.65 /

+1.43 (+1.59%)

, DTIL

Precision BioSciences

$6.91 /

+0.05 (+0.73%)

, GSK

GlaxoSmithKline

$35.34 /

+0.26 (+0.74%)

, JNJ

Johnson & Johnson

$145.30 /

+0.13 (+0.09%)

, PSTX

Poseida Therapeutics

$10.93 /

+ (+0.00%)

, REGN

Regeneron

$579.36 /

+3.63 (+0.63%)

, SGEN

Seagen

$197.10 /

-3.24 (-1.62%)

Biotech Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SGEN Seagen
$197.10 /

-3.24 (-1.62%)

REGN Regeneron
$579.36 /

+3.63 (+0.63%)

PSTX Poseida Therapeutics
$10.93 /

+ (+0.00%)

JNJ Johnson & Johnson
$145.30 /

+0.13 (+0.09%)

GSK GlaxoSmithKline
$35.34 /

+0.26 (+0.74%)

DTIL Precision BioSciences
$6.91 /

+0.05 (+0.73%)

CRSP Crispr Therapeutics
$91.65 /

+1.43 (+1.59%)

BMY Bristol-Myers
$60.41 /

-0.355 (-0.58%)

BLUE Bluebird Bio
$55.37 /

-0.13 (-0.23%)

AMGN Amgen
$227.59 /

-0.31 (-0.14%)

ALLO Allogene Therapeutics
$36.00 /

+0.64 (+1.81%)

ALLO Allogene Therapeutics
$36.00 /

+0.64 (+1.81%)

10/22/20 RBC Capital
Allogene Therapeutics initiated with an Outperform at RBC Capital
10/22/20 RBC Capital
Crispr Therapeutics initiated with a Sector Perform at RBC Capital
10/21/20 Stifel
Crispr Therapeutics price target raised to $93 from $75 at Stifel
10/15/20 Roth Capital
Allogene's new collaboration may enrich anticancer portfolio, says Roth Capital
AMGN Amgen
$227.59 /

-0.31 (-0.14%)

10/22/20 Oppenheimer
Amgen price target lowered to $275 from $280 at Oppenheimer
10/09/20
Fly Intel: Top five analyst downgrades
10/09/20 Truist
Amgen downgraded to Hold from Buy at Truist
10/09/20 Bernstein
Amgen downgraded to Market Perform from Outperform at Bernstein
BLUE Bluebird Bio
$55.37 /

-0.13 (-0.23%)

10/20/20 Mizuho
Mizuho starts Bluebird Bio with Buy rating, $123 price target
10/19/20 Mizuho
Bluebird Bio initiated with a Buy at Mizuho
09/22/20 Oppenheimer
Bluebird Bio review timeline consistent with expectations, says Oppenheimer
BMY Bristol-Myers
$60.41 /

-0.355 (-0.58%)

09:55 Today
Fly Intel: Pre-market Movers
08:56 Today Truist
Bristol-Myers initiated with a Hold at Truist
10/19/20
Fly Intel: Top five analyst upgrades
10/19/20 Guggenheim
Bristol-Myers upgraded to Buy after positive Opdivo data at Guggenheim
CRSP Crispr Therapeutics
$91.65 /

+1.43 (+1.59%)

10/22/20 Chardan
Crispr Therapeutics price target raised to $110 from $100 at Chardan
10/22/20 Canaccord
Crispr Therapeutics price target raised to $120 from $110 at Canaccord
10/22/20 Citi
Crispr Therapeutics price target raised to $47 from $31 at Citi
DTIL Precision BioSciences
$6.91 /

+0.05 (+0.73%)

07/27/20 BTIG
Precision BioSciences assumed with a Buy at BTIG
05/18/20 H.C. Wainwright
Precision BioSciences could have 'significant upside,' says H.C. Wainwright
04/02/20 Goldman Sachs
Precision BioSciences downgraded to Neutral from Buy at Goldman Sachs
GSK GlaxoSmithKline
$35.34 /

+0.26 (+0.74%)

10/15/20 SVB Leerink
SVB Leerink sees possible opportunity for Amarin to 'salvage Vascepa' in U.S.
10/12/20 UBS
GlaxoSmithKline price target lowered to 1,730 GBp from 1,800 GBp at UBS
10/09/20 Morgan Stanley
GlaxoSmithKline price target lowered to 1,695 GBp from 1,700 GBp at Morgan Stanley
10/08/20 JPMorgan
JPMorgan backs Neutral on GSK ahead of Q3 results
JNJ Johnson & Johnson
$145.30 /

+0.13 (+0.09%)

10/14/20 Credit Suisse
Johnson & Johnson price target raised to $168 from $163 at Credit Suisse
10/14/20 Cantor Fitzgerald
Johnson & Johnson price target raised to $180 from $168 at Cantor Fitzgerald
10/13/20 Wells Fargo
Emergent selloff on J&J study pause an overreaction, says Wells Fargo
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
PSTX Poseida Therapeutics
$10.93 /

+ (+0.00%)

08/20/20 Piper Sandler
Poseida Therapeutics's P-BCMA-101 data expected by year-end, says Piper Sandler
08/17/20 Piper Sandler
Poseida Therapeutics' halt of P-PSMA-101 may have been preventable, says Piper
08/04/20
Fly Intel: Top five analyst initiations
08/04/20 William Blair
Poseida Therapeutics initiated with an Outperform at William Blair
REGN Regeneron
$579.36 /

+3.63 (+0.63%)

10/08/20 Benchmark
Regeneron antibody data 'more convincing' than Eli Lilly's, says Benchmark
10/07/20 Canaccord
Eli Lilly data further validates COVID antibody therapy, says Canaccord
10/05/20 Cantor Fitzgerald
Regeneron upgraded to Overweight from Neutral at Cantor Fitzgerald
10/05/20 Cantor Fitzgerald
Regeneron upgraded to Overweight from Neutral at Cantor Fitzgerald
SGEN Seagen
$197.10 /

-3.24 (-1.62%)

10/13/20 JMP Securities
Seagen price target raised to $216 from $200 at JMP Securities
09/22/20 Stifel
Seattle Genetics price target raised to $165 from $145 at Stifel
09/22/20 JMP Securities
Seattle Genetics price target raised to $200 from $185 at JMP Securities
09/21/20 Piper Sandler
Tisotumab data sets Seattle Genetics up for another approval, says Piper Sandler
SGEN Seagen
$197.10 /

-3.24 (-1.62%)

REGN Regeneron
$579.36 /

+3.63 (+0.63%)

PSTX Poseida Therapeutics
$10.93 /

+ (+0.00%)

JNJ Johnson & Johnson
$145.30 /

+0.13 (+0.09%)

GSK GlaxoSmithKline
$35.34 /

+0.26 (+0.74%)

DTIL Precision BioSciences
$6.91 /

+0.05 (+0.73%)

CRSP Crispr Therapeutics
$91.65 /

+1.43 (+1.59%)

BMY Bristol-Myers
$60.41 /

-0.355 (-0.58%)

BLUE Bluebird Bio
$55.37 /

-0.13 (-0.23%)

AMGN Amgen
$227.59 /

-0.31 (-0.14%)

ALLO Allogene Therapeutics
$36.00 /

+0.64 (+1.81%)

  • 10
    Jul
  • 01
    Jul
  • 02
    Jun
  • 27
    May
  • 19
    May
  • 21
    Nov
REGN Regeneron
$579.36 /

+3.63 (+0.63%)

JNJ Johnson & Johnson
$145.30 /

+0.13 (+0.09%)

GSK GlaxoSmithKline
$35.34 /

+0.26 (+0.74%)

BMY Bristol-Myers
$60.41 /

-0.355 (-0.58%)

AMGN Amgen
$227.59 /

-0.31 (-0.14%)

SGEN Seagen
$197.10 /

-3.24 (-1.62%)

REGN Regeneron
$579.36 /

+3.63 (+0.63%)

PSTX Poseida Therapeutics
$10.93 /

+ (+0.00%)

JNJ Johnson & Johnson
$145.30 /

+0.13 (+0.09%)

GSK GlaxoSmithKline
$35.34 /

+0.26 (+0.74%)

DTIL Precision BioSciences
$6.91 /

+0.05 (+0.73%)

CRSP Crispr Therapeutics
$91.65 /

+1.43 (+1.59%)

BMY Bristol-Myers
$60.41 /

-0.355 (-0.58%)

BLUE Bluebird Bio
$55.37 /

-0.13 (-0.23%)

AMGN Amgen
$227.59 /

-0.31 (-0.14%)

ALLO Allogene Therapeutics
$36.00 /

+0.64 (+1.81%)

REGN Regeneron
$579.36 /

+3.63 (+0.63%)

JNJ Johnson & Johnson
$145.30 /

+0.13 (+0.09%)

GSK GlaxoSmithKline
$35.34 /

+0.26 (+0.74%)

BMY Bristol-Myers
$60.41 /

-0.355 (-0.58%)

AMGN Amgen
$227.59 /

-0.31 (-0.14%)

Initiation
Fly Intel: Pre-market Movers » 09:55
10/23/20
10/23
09:55
10/23/20
09:55
SPCE

Virgin Galactic

$20.05 /

-0.68 (-3.28%)

, HQY

HealthEquity

$56.97 /

+1.79 (+3.24%)

, SJR

Shaw Communications

$17.82 /

+0.06 (+0.34%)

, SSTK

Shutterstock

$62.30 /

+1.95 (+3.23%)

, PFE

Pfizer

$37.83 /

+0.4 (+1.07%)

, MRK

Merck

$79.61 /

+0.4 (+0.50%)

, LLY

Eli Lilly

$143.11 /

+1.37 (+0.97%)

, BMY

Bristol-Myers

$60.87 /

+0.11 (+0.18%)

, ABBV

AbbVie

$84.10 /

-0.2 (-0.24%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Virgin Galactic (SPCE) initiated with a Neutral at Goldman Sachs. 2. HealthEquity (HQY) initiated with an Outperform at RBC Capital. 3. Shaw Communications (SJR) initiated with an Equal Weight at Morgan Stanley. 4. Shutterstock (SSTK) initiated with a Buy at Stifel. 5. Pfizer (PFE), Merck (MRK), Eli Lilly (LLY) and AbbVie (ABBV) all initiated with a Buy at Truist, while Bristol-Myers (BMY) initiated with a Hold at the firm. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
SSTK Shutterstock
$62.30 /

+1.95 (+3.23%)

SPCE Virgin Galactic
$20.05 /

-0.68 (-3.28%)

SJR Shaw Communications
$17.82 /

+0.06 (+0.34%)

PFE Pfizer
$37.83 /

+0.4 (+1.07%)

MRK Merck
$79.61 /

+0.4 (+0.50%)

LLY Eli Lilly
$143.11 /

+1.37 (+0.97%)

HQY HealthEquity
$56.97 /

+1.79 (+3.24%)

BMY Bristol-Myers
$60.87 /

+0.11 (+0.18%)

ABBV AbbVie
$84.10 /

-0.2 (-0.24%)

SPCE Virgin Galactic
$20.05 /

-0.68 (-3.28%)

04:48 Today Goldman Sachs
Virgin Galactic initiated with a Neutral at Goldman Sachs
09/28/20
Fly Intel: Top five analyst initiations
09/28/20 Susquehanna
Susquehanna starts Virgin Galactic with Positive rating, $20 price target
09/28/20 BofA
BofA starts Virgin Galactic with Buy rating, $35 price target
HQY HealthEquity
$56.97 /

+1.79 (+3.24%)

06:36 Today RBC Capital
HealthEquity initiated with an Outperform at RBC Capital
09/10/20 Deutsche Bank
HealthEquity price target raised to $60 from $57 at Deutsche Bank
09/09/20 Barrington
HealthEquity price target raised to $70 from $65 at Barrington
09/09/20 SVB Leerink
HealthEquity price target raised to $64 from $51 at SVB Leerink
SJR Shaw Communications
$17.82 /

+0.06 (+0.34%)

08:05 Today Morgan Stanley
Shaw Communications initiated with an Equal Weight at Morgan Stanley
10/02/20
Fly Intel: Top five analyst initiations
10/02/20 Barclays
Shaw Communications initiated with an Equal Weight at Barclays
09/11/20 National Bank
Shaw Communications price target raised to C$28 from C$27 at National Bank
SSTK Shutterstock
$62.30 /

+1.95 (+3.23%)

07:05 Today Stifel
Shutterstock initiated with a Buy at Stifel
06:19 Today JMP Securities
Shutterstock initiated with an Outperform at JMP Securities
09/29/20 BofA
Shutterstock initiated with a Buy at BofA
09/29/20 BofA
Shutterstock initiated with a Buy at BofA
PFE Pfizer
$37.83 /

+0.4 (+1.07%)

09:24 Today Piper Sandler
Ultragenyx deal with Solid Biosciences looks 'solid,' says Piper Sandler
08:49 Today Truist
Pfizer initiated with a Buy at Truist
10/14/20 SVB Leerink
BioNTech price target raised to $69 from $62 at SVB Leerink
10/12/20
Fly Intel: Top five analyst downgrades
MRK Merck
$79.61 /

+0.4 (+0.50%)

08:51 Today Truist
Merck initiated with a Buy at Truist
10/16/20 JPMorgan
Merck price target raised to $105 from $98 at JPMorgan
10/08/20 Piper Sandler
Moderna regains rights to adult RSV vaccine mRNA-1172, Piper ups target to $136
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
LLY Eli Lilly
$143.11 /

+1.37 (+0.97%)

08:53 Today Truist
Eli Lilly initiated with a Buy at Truist
10/16/20 JPMorgan
Eli Lilly price target raised to $200 from $190 at JPMorgan
10/14/20 JPMorgan
Eli Lilly risk/reward favorable into tirzepatide readout, says JPMorgan
10/14/20 Citi
Karuna Therapeutics trial news a positive, says Citi
BMY Bristol-Myers
$60.87 /

+0.11 (+0.18%)

08:56 Today Truist
Bristol-Myers initiated with a Hold at Truist
10/19/20
Fly Intel: Top five analyst upgrades
10/19/20 Guggenheim
Bristol-Myers upgraded to Buy after positive Opdivo data at Guggenheim
10/19/20 Guggenheim
Bristol-Myers upgraded to Buy from Neutral at Guggenheim
ABBV AbbVie
$84.10 /

-0.2 (-0.24%)

08:58 Today Truist
AbbVie initiated with a Buy at Truist
10/20/20 Goldman Sachs
Galapagos downgraded to Sell from Neutral at Goldman Sachs
10/16/20 JPMorgan
AbbVie price target raised to $120 from $115 at JPMorgan
09/29/20 Berenberg
AbbVie initiated with a Hold at Berenberg
SSTK Shutterstock
$62.30 /

+1.95 (+3.23%)

SPCE Virgin Galactic
$20.05 /

-0.68 (-3.28%)

SJR Shaw Communications
$17.82 /

+0.06 (+0.34%)

PFE Pfizer
$37.83 /

+0.4 (+1.07%)

MRK Merck
$79.61 /

+0.4 (+0.50%)

LLY Eli Lilly
$143.11 /

+1.37 (+0.97%)

HQY HealthEquity
$56.97 /

+1.79 (+3.24%)

BMY Bristol-Myers
$60.87 /

+0.11 (+0.18%)

ABBV AbbVie
$84.10 /

-0.2 (-0.24%)

  • 12
    Aug
  • 06
    Aug
  • 09
    Jul
  • 03
    Jun
  • 20
    May
SPCE Virgin Galactic
$20.05 /

-0.68 (-3.28%)

PFE Pfizer
$37.83 /

+0.4 (+1.07%)

MRK Merck
$79.61 /

+0.4 (+0.50%)

LLY Eli Lilly
$143.11 /

+1.37 (+0.97%)

BMY Bristol-Myers
$60.87 /

+0.11 (+0.18%)

SSTK Shutterstock
$62.30 /

+1.95 (+3.23%)

SPCE Virgin Galactic
$20.05 /

-0.68 (-3.28%)

PFE Pfizer
$37.83 /

+0.4 (+1.07%)

MRK Merck
$79.61 /

+0.4 (+0.50%)

LLY Eli Lilly
$143.11 /

+1.37 (+0.97%)

HQY HealthEquity
$56.97 /

+1.79 (+3.24%)

BMY Bristol-Myers
$60.87 /

+0.11 (+0.18%)

ABBV AbbVie
$84.10 /

-0.2 (-0.24%)

SPCE Virgin Galactic
$20.05 /

-0.68 (-3.28%)

SJR Shaw Communications
$17.82 /

+0.06 (+0.34%)

PFE Pfizer
$37.83 /

+0.4 (+1.07%)

MRK Merck
$79.61 /

+0.4 (+0.50%)

LLY Eli Lilly
$143.11 /

+1.37 (+0.97%)

HQY HealthEquity
$56.97 /

+1.79 (+3.24%)

BMY Bristol-Myers
$60.87 /

+0.11 (+0.18%)

ABBV AbbVie
$84.10 /

-0.2 (-0.24%)

Initiation
Bristol-Myers initiated with a Hold at Truist » 08:56
10/23/20
10/23
08:56
10/23/20
08:56
BMY

Bristol-Myers

$60.76 /

+0.73 (+1.22%)

Truist analyst Gregg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$60.76 /

+0.73 (+1.22%)

BMY Bristol-Myers
$60.76 /

+0.73 (+1.22%)

10/19/20
Fly Intel: Top five analyst upgrades
10/19/20 Guggenheim
Bristol-Myers upgraded to Buy after positive Opdivo data at Guggenheim
10/19/20 Guggenheim
Bristol-Myers upgraded to Buy from Neutral at Guggenheim
10/16/20 JPMorgan
Bristol-Myers price target raised to $78 from $74 at JPMorgan
BMY Bristol-Myers
$60.76 /

+0.73 (+1.22%)

BMY Bristol-Myers
$60.76 /

+0.73 (+1.22%)

BMY Bristol-Myers
$60.76 /

+0.73 (+1.22%)

BMY Bristol-Myers
$60.76 /

+0.73 (+1.22%)

Options
Largest borrow rate increases among liquid names » 08:45
10/23/20
10/23
08:45
10/23/20
08:45
FTAI

Fortress Transportation

$17.20 /

+0.85 (+5.20%)

, SNDL

Sundial Growers

$0.17 /

+0.0028 (+1.63%)

, NAK

Northern Dynasty

$1.01 /

+ (+0.00%)

, PIC

Pivotal Investment Corp. II

$10.18 /

-0.01 (-0.10%)

, ACI

Albertsons

$14.59 /

-0.275 (-1.85%)

, CRBP

Corbus Pharmaceuticals

$1.04 /

+0.0875 (+9.19%)

, IMAX

Imax

$11.67 /

+0.32 (+2.82%)

, ALT

Altimmune

$11.71 /

+0.67 (+6.07%)

, HSBC

HSBC

$20.18 /

+0.3 (+1.51%)

, SPH

Suburban Propane

$17.59 /

+0.725 (+4.30%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Fortress Transportation (FTAI) 8.75% +0.58, Sundial Growers (SNDL) 37.61% +0.45, Northern Dynasty (NAK) 21.35% +0.39, Pivotal Investment Corp (PIC) 3.14% +0.29, Albertsons (ACI) 8.66% +0.15, Corbus Pharmaceuticals (CRBP) 9.86% +0.14, IMAX (IMAX) 0.39% +0.10, Altimmune (ALT) 1.13% +0.08, HSBC (HSBC) 0.39% +0.08, and Suburban Propane (SPH) 2.38% +0.08.

ShowHide Related Items >><<
SPH Suburban Propane
$17.59 /

+0.725 (+4.30%)

SNDL Sundial Growers
$0.17 /

+0.0028 (+1.63%)

PIC Pivotal Investment Corp. II
$10.18 /

-0.01 (-0.10%)

NAK Northern Dynasty
$1.01 /

+ (+0.00%)

IMAX Imax
$11.67 /

+0.32 (+2.82%)

HSBC HSBC
$20.18 /

+0.3 (+1.51%)

FTAI Fortress Transportation
$17.20 /

+0.85 (+5.20%)

CRBP Corbus Pharmaceuticals
$1.04 /

+0.0875 (+9.19%)

ALT Altimmune
$11.71 /

+0.67 (+6.07%)

ACI Albertsons
$14.59 /

-0.275 (-1.85%)

FTAI Fortress Transportation
$17.20 /

+0.85 (+5.20%)

10/19/20 Compass Point
Fortress Transportation initiated with a Buy at Compass Point
09/03/20 B. Riley Securities
Fortress Transportation transferred with Buy rating at B. Riley FBR
07/17/20 Benchmark
Fortress Transportation initiated with a Buy at Benchmark
12/02/19 BTIG
Fortress Transportation initiated with a Buy at BTIG
SNDL Sundial Growers
$0.17 /

+0.0028 (+1.63%)

08/17/20 CIBC
Sundial Growers upgraded to Neutral from Underperformer at CIBC
06/29/20 BMO Capital
Sundial Growers upgraded to Market Perform from Underperform at BMO Capital
04/02/20 BMO Capital
Sundial Growers downgraded to Underperform from Market Perform at BMO Capital
02/24/20 Cowen
Cowen cautious on Canada cannabis, downgrades Aurora, Sundial, Tilray
NAK Northern Dynasty
$1.01 /

+ (+0.00%)

07/28/20 BMO Capital
Northern Dynasty price target raised to C$3.50 from C$1.50 at BMO Capital
06/29/20 TD Securities
Northern Dynasty price target raised to C$2.25 from C$1.30 at TD Securities
05/14/20 TD Securities
Northern Dynasty price target raised to C$1.30 from C$0.75 at TD Securities
PIC Pivotal Investment Corp. II
$10.18 /

-0.01 (-0.10%)

ACI Albertsons
$14.59 /

-0.275 (-1.85%)

08:25 Today Evercore ISI
Kroger downgraded to In Line from Outperform at Evercore ISI
10/06/20
Fly Intel: Top five analyst initiations
10/06/20 Northcoast
Albertsons initiated with a Buy at Northcoast
09/25/20 Tigress Financial
Albertsons initiated with a Buy at Tigress Financial
CRBP Corbus Pharmaceuticals
$1.04 /

+0.0875 (+9.19%)

10/08/20 H.C. Wainwright
Corbus Pharmaceuticals price target lowered to $3 from $6 at H.C. Wainwright
10/06/20 Roth Capital
Corbus Pharmaceuticals price target lowered to $1.22 from $3 at Roth Capital
09/08/20 Jefferies
Corbus Pharmaceuticals downgraded to Hold from Buy at Jefferies
09/08/20 Oppenheimer
Corbus Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
IMAX Imax
$11.67 /

+0.32 (+2.82%)

10/12/20 B. Riley Securities
Imax price target lowered to $18 from $21 at B. Riley Securities
09/16/20 B. Riley Securities
B. Riley FBR reiterates Buy on Imax with China easing capacity restrictions
09/08/20 B. Riley Securities
IMAX box office for "Tenet' supports positive thesis, says B. Riley FBR
09/04/20 B. Riley Securities
IMAX price target raised to $21 from $18 at B. Riley FBR
ALT Altimmune
$11.71 /

+0.67 (+6.07%)

10/12/20 Piper Sandler
Piper sees AdCOVID pre-clinical data helping benchmark Altimmune COVID program
09/25/20 B. Riley Securities
Altimmune initiated with a Buy at B. Riley FBR
09/22/20 Piper Sandler
Altimmune nearing two 'key stock-moving events,' says Piper Sandler
09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
HSBC HSBC
$20.18 /

+0.3 (+1.51%)

10/06/20 UBS
HSBC price target lowered to 310 GBp from 410 GBp at UBS
09/21/20 Wells Fargo
Money laundering headlines creating extra headline risk for banks, says Wells
08/11/20 Morgan Stanley
HSBC upgraded to Equal Weight from Underweight at Morgan Stanley
08/07/20 Berenberg
HSBC price target lowered to 380 GBp from 390 GBp at Berenberg
SPH Suburban Propane
$17.59 /

+0.725 (+4.30%)

10/21/20 Argus
Suburban Propane upgraded to Hold from Sell at Argus
10/21/20 Argus
Suburban Propane upgraded to Hold from Sell at Argus
02/11/20 Argus
Suburban Propane downgraded to Sell from Hold at Argus
SPH Suburban Propane
$17.59 /

+0.725 (+4.30%)

SNDL Sundial Growers
$0.17 /

+0.0028 (+1.63%)

IMAX Imax
$11.67 /

+0.32 (+2.82%)

HSBC HSBC
$20.18 /

+0.3 (+1.51%)

FTAI Fortress Transportation
$17.20 /

+0.85 (+5.20%)

CRBP Corbus Pharmaceuticals
$1.04 /

+0.0875 (+9.19%)

ACI Albertsons
$14.59 /

-0.275 (-1.85%)

  • 14
    Jul
  • 26
    Jun
  • 11
    May
  • 07
    Feb
IMAX Imax
$11.67 /

+0.32 (+2.82%)

HSBC HSBC
$20.18 /

+0.3 (+1.51%)

ACI Albertsons
$14.59 /

-0.275 (-1.85%)

PIC Pivotal Investment Corp. II
$10.18 /

-0.01 (-0.10%)

IMAX Imax
$11.67 /

+0.32 (+2.82%)

HSBC HSBC
$20.18 /

+0.3 (+1.51%)

CRBP Corbus Pharmaceuticals
$1.04 /

+0.0875 (+9.19%)

ALT Altimmune
$11.71 /

+0.67 (+6.07%)

ACI Albertsons
$14.59 /

-0.275 (-1.85%)

SNDL Sundial Growers
$0.17 /

+0.0028 (+1.63%)

PIC Pivotal Investment Corp. II
$10.18 /

-0.01 (-0.10%)

NAK Northern Dynasty
$1.01 /

+ (+0.00%)

IMAX Imax
$11.67 /

+0.32 (+2.82%)

HSBC HSBC
$20.18 /

+0.3 (+1.51%)

FTAI Fortress Transportation
$17.20 /

+0.85 (+5.20%)

CRBP Corbus Pharmaceuticals
$1.04 /

+0.0875 (+9.19%)

ALT Altimmune
$11.71 /

+0.67 (+6.07%)

ACI Albertsons
$14.59 /

-0.275 (-1.85%)

Yesterday
On The Fly
Fly Intel: After-Hours Movers » 18:50
10/22/20
10/22
18:50
10/22/20
18:50
SCKT

Socket Mobile

$1.42 /

-0.05 (-3.40%)

, SAM

Boston Beer

$918.98 /

+6.49 (+0.71%)

, FFBC

First Financial Bancorp

$14.53 /

+0.68 (+4.91%)

, BOOM

DMC Global

$34.55 /

+1.25 (+3.75%)

, MAT

Mattel

$12.93 /

+0.475 (+3.81%)

, COF

Capital One

$76.98 /

+3.24 (+4.39%)

, SAVA

Cassava Sciences

$8.84 /

-0.07 (-0.79%)

, GILD

Gilead

$60.68 /

+0.44 (+0.73%)

, MIST

Milestone Pharmaceuticals

$6.99 /

+0.18 (+2.64%)

, CYBE

Cyberoptics

$37.71 /

+1.31 (+3.60%)

, LLNW

Limelight Networks

$6.18 /

+0.05 (+0.82%)

, USX

U.S. Xpress Enterprises

$9.34 /

+0.02 (+0.21%)

, EHTH

eHealth

$82.01 /

+0.21 (+0.26%)

, INTC

Intel

$53.98 /

+0.49 (+0.92%)

, MANH

Manhattan Associates

$103.40 /

+4.62 (+4.68%)

, STX

Seagate

$51.80 /

+0.06 (+0.12%)

, VRSN

VeriSign

$207.96 /

+2.22 (+1.08%)

, RHI

Robert Half

$56.48 /

+1.1298 (+2.04%)

Check out this evening's…

ShowHide Related Items >><<
VRSN VeriSign
$207.96 /

+2.22 (+1.08%)

USX U.S. Xpress Enterprises
$9.34 /

+0.02 (+0.21%)

STX Seagate
$51.80 /

+0.06 (+0.12%)

SAVA Cassava Sciences
$8.84 /

-0.07 (-0.79%)

SAM Boston Beer
$918.98 /

+6.49 (+0.71%)

RHI Robert Half
$56.48 /

+1.1298 (+2.04%)

MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

MAT Mattel
$12.93 /

+0.475 (+3.81%)

MANH Manhattan Associates
$103.40 /

+4.62 (+4.68%)

LLNW Limelight Networks
$6.18 /

+0.05 (+0.82%)

INTC Intel
$53.98 /

+0.49 (+0.92%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

EHTH eHealth
$82.01 /

+0.21 (+0.26%)

COF Capital One
$76.98 /

+3.24 (+4.39%)

BOOM DMC Global
$34.55 /

+1.25 (+3.75%)

SCKT Socket Mobile
$1.42 /

-0.05 (-3.40%)

SAM Boston Beer
$918.98 /

+6.49 (+0.71%)

10/15/20 Deutsche Bank
Boston Beer price target raised to $835 from $656 at Deutsche Bank
09/03/20 MKM Partners
Boston Beer price target raised to $780 from $353 at MKM Partners
09/02/20 Citi
Boston Beer price target raised to $1,015 from $815 at Citi
08/27/20 Guggenheim
Boston Beer price target raised to $977 from $822 at Guggenheim
FFBC First Financial Bancorp
$14.53 /

+0.68 (+4.91%)

BOOM DMC Global
$34.55 /

+1.25 (+3.75%)

09/11/20 Sidoti
DMC Global re-initiated with a Neutral at Sidoti
08/20/20 Stifel
DMC Global price target raised to $44 from $33 at Stifel
03/09/20 Roth Capital
DMC Global downgraded to Neutral from Buy at Roth Capital
02/21/20 Roth Capital
DMC Global earnings exceed preannouncement, says Roth Capital
MAT Mattel
$12.93 /

+0.475 (+3.81%)

10/19/20 JPMorgan
Mattel price target raised to $17.50 from $15 at JPMorgan
10/08/20 Jefferies
Set-up for toy companies for Q3 'favorable,' says Jefferies
07/24/20 MKM Partners
Mattel price target raised to $13 from $9 at MKM Partners
06/03/20
Fly Intel: Top five analyst upgrades
COF Capital One
$76.98 /

+3.24 (+4.39%)

10/09/20 JPMorgan
Capital One price target raised to $86.50 from $72 at JPMorgan
07/31/20 Wolfe Research
Capital One initiated with an Outperform at Wolfe Research
07/22/20 Oppenheimer
Capital One price target raised to $69 from $63 at Oppenheimer
07/22/20 Piper Sandler
Capital One price target raised to $82 from $77 at Piper Sandler
SAVA Cassava Sciences
$8.84 /

-0.07 (-0.79%)

10/22/20 Cantor Fitzgerald
Cassava Sciences initiated with an Overweight at Cantor Fitzgerald
09/23/20 H.C. Wainwright
Cassava Sciences upgraded to Buy from Neutral at H.C. Wainwright
09/14/20 Maxim
Cassava upgraded to Buy at Maxim after second analysis of AD drug data
09/14/20 Maxim
Cassava Sciences upgraded to Buy from Hold at Maxim
GILD Gilead
$60.68 /

+0.44 (+0.73%)

10/16/20 Baird
Baird negative on Gilead clinical data for remdesivir
10/16/20 Citi
Gilead investors may start questioning Galapagos collaboration, says Citi
09/30/20 Jefferies
Regeneron antibody cocktail results positive for vaccines, says Jefferies
09/24/20 H.C. Wainwright
Durect study designed to support full approval, says H.C. Wainwright
MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

07/29/20 Oppenheimer
Oppenheimer upgrades Milestone to Outperform on 'best-case' FDA outcome
07/29/20 Oppenheimer
Milestone Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
07/24/20
Fly Intel: Top five analyst upgrades
07/24/20 Jefferies
Jefferies upgrades Milestone to Buy on 'major' FDA win
CYBE Cyberoptics
$37.71 /

+1.31 (+3.60%)

06/18/20 Craig-Hallum
Cyberoptics price target raised to $43 from $33 at Craig-Hallum
06/09/20
Cyberoptics downgraded to Neutral from Buy at Dougherty
04/24/20 Lake Street
Cyberoptics investors to be pleased with 'impressive' guidance, says Lake Street
02/20/20 Craig-Hallum
Cyberoptics price target raised to $29 from $20 at Craig-Hallum
LLNW Limelight Networks
$6.18 /

+0.05 (+0.82%)

10/15/20 DA Davidson
Fastly price target lowered to $105 from $115 at DA Davidson
09/18/20 Truist
Limelight Networks initiated with a Buy at Truist
09/18/20 Truist
Limelight Networks initiated with a Buy at Truist
07/21/20 Lake Street
Limelight Networks price target raised to $9 from $8 at Lake Street
USX U.S. Xpress Enterprises
$9.34 /

+0.02 (+0.21%)

10/15/20 Stifel
U.S. Xpress Enterprises upgraded to Buy amid tight spot market at Stifel
10/15/20 Stifel
U.S. Xpress Enterprises upgraded to Buy from Hold at Stifel
07/29/20 BofA
U.S. Xpress Enterprises upgraded to Buy from Neutral at BofA
07/29/20 BofA
U.S. Xpress Enterprises upgraded to Buy from Neutral at BofA
EHTH eHealth
$82.01 /

+0.21 (+0.26%)

10/07/20 Deutsche Bank
eHealth growth unlikely impacted by Walmart entrance, says Deutsche Bank
10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
10/06/20 Citi
Walmart entry a 'significant competitive threat' to eHealth, says Citi
09/25/20 Goldman Sachs
eHealth initiated with a Buy at Goldman Sachs
INTC Intel
$53.98 /

+0.49 (+0.92%)

10/21/20 Susquehanna
Intel checks show PC strength continues, says Susquehanna
10/20/20 Oppenheimer
Intel deal a positive for company and broader memory group, says Oppenheimer
10/20/20 Roth Capital
Roth Capital 'encouraged' by Intel's non-core divestiture efforts
10/19/20 Lynx
Intel/SK Hynix deal impact to Western, Micron 'manageable,' says Lynx
MANH Manhattan Associates
$103.40 /

+4.62 (+4.68%)

10/15/20 Truist
Manhattan Associates price target raised to $120 from $110 at Truist
07/06/20 Benchmark
Manhattan Associates price target raised to $105 from $83 at Benchmark
05/28/20 Truist
Manhattan Associates price target raised to $98 from $80 at SunTrust
05/21/20 Truist
Manhattan Associates price target raised to $80 from $70 at SunTrust
STX Seagate
$51.80 /

+0.06 (+0.12%)

10/21/20 RBC Capital
Seagate price target raised to $52 from $48 at RBC Capital
10/13/20 Morgan Stanley
Morgan Stanley upgrades IT Hardware industry view to Attractive from In-Line
09/22/20 Susquehanna
Susquehanna updates estimates for Western Digital and Seagate
09/15/20 Northland
Seagate initiated with an Outperform at Northland
VRSN VeriSign
$207.96 /

+2.22 (+1.08%)

04/24/20 Baird
VeriSign price target raised to $250 from $220 at Baird
RHI Robert Half
$56.48 /

+1.1298 (+2.04%)

07/27/20 Truist
Robert Half price target raised to $52 from $40 at SunTrust
05/21/20 Credit Suisse
Robert Half upgraded to Neutral on valuation at Credit Suisse
05/21/20 Credit Suisse
Robert Half upgraded to Neutral from Underperform at Credit Suisse
04/24/20 BMO Capital
Robert Half price target raised to $53 from $45 at BMO Capital
VRSN VeriSign
$207.96 /

+2.22 (+1.08%)

USX U.S. Xpress Enterprises
$9.34 /

+0.02 (+0.21%)

STX Seagate
$51.80 /

+0.06 (+0.12%)

SCKT Socket Mobile
$1.42 /

-0.05 (-3.40%)

SAVA Cassava Sciences
$8.84 /

-0.07 (-0.79%)

SAM Boston Beer
$918.98 /

+6.49 (+0.71%)

RHI Robert Half
$56.48 /

+1.1298 (+2.04%)

MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

MAT Mattel
$12.93 /

+0.475 (+3.81%)

MANH Manhattan Associates
$103.40 /

+4.62 (+4.68%)

LLNW Limelight Networks
$6.18 /

+0.05 (+0.82%)

INTC Intel
$53.98 /

+0.49 (+0.92%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

FFBC First Financial Bancorp
$14.53 /

+0.68 (+4.91%)

EHTH eHealth
$82.01 /

+0.21 (+0.26%)

CYBE Cyberoptics
$37.71 /

+1.31 (+3.60%)

COF Capital One
$76.98 /

+3.24 (+4.39%)

BOOM DMC Global
$34.55 /

+1.25 (+3.75%)

  • 23
    Oct
  • 04
    Mar
  • 20
    Nov
STX Seagate
$51.80 /

+0.06 (+0.12%)

INTC Intel
$53.98 /

+0.49 (+0.92%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

EHTH eHealth
$82.01 /

+0.21 (+0.26%)

COF Capital One
$76.98 /

+3.24 (+4.39%)

USX U.S. Xpress Enterprises
$9.34 /

+0.02 (+0.21%)

STX Seagate
$51.80 /

+0.06 (+0.12%)

SAVA Cassava Sciences
$8.84 /

-0.07 (-0.79%)

SAM Boston Beer
$918.98 /

+6.49 (+0.71%)

MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

MAT Mattel
$12.93 /

+0.475 (+3.81%)

LLNW Limelight Networks
$6.18 /

+0.05 (+0.82%)

INTC Intel
$53.98 /

+0.49 (+0.92%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

EHTH eHealth
$82.01 /

+0.21 (+0.26%)

CYBE Cyberoptics
$37.71 /

+1.31 (+3.60%)

COF Capital One
$76.98 /

+3.24 (+4.39%)

BOOM DMC Global
$34.55 /

+1.25 (+3.75%)

STX Seagate
$51.80 /

+0.06 (+0.12%)

SAVA Cassava Sciences
$8.84 /

-0.07 (-0.79%)

MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

MAT Mattel
$12.93 /

+0.475 (+3.81%)

LLNW Limelight Networks
$6.18 /

+0.05 (+0.82%)

INTC Intel
$53.98 /

+0.49 (+0.92%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

EHTH eHealth
$82.01 /

+0.21 (+0.26%)

COF Capital One
$76.98 /

+3.24 (+4.39%)

Initiation
Cassava Sciences initiated with an Overweight at Cantor Fitzgerald » 16:11
10/22/20
10/22
16:11
10/22/20
16:11
SAVA

Cassava Sciences

$8.82 /

-0.09 (-1.01%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Charles Duncan initiated coverage of Cassava Sciences with an Overweight rating and $24 price target. Cassava's first-in-class filamin A is a novel drug target with a differentiated mechanism of action to address Alzheimer's disease, Duncan tells investors.

ShowHide Related Items >><<
SAVA Cassava Sciences
$8.82 /

-0.09 (-1.01%)

SAVA Cassava Sciences
$8.82 /

-0.09 (-1.01%)

09/23/20 H.C. Wainwright
Cassava Sciences upgraded to Buy from Neutral at H.C. Wainwright
09/14/20 Maxim
Cassava upgraded to Buy at Maxim after second analysis of AD drug data
09/14/20 Maxim
Cassava Sciences upgraded to Buy from Hold at Maxim
05/18/20 H.C. Wainwright
Cassava Sciences downgraded to Neutral from Buy at H.C. Wainwright
SAVA Cassava Sciences
$8.82 /

-0.09 (-1.01%)

SAVA Cassava Sciences
$8.82 /

-0.09 (-1.01%)

SAVA Cassava Sciences
$8.82 /

-0.09 (-1.01%)

Recommendations
Novavax price target lowered to $223 from $257 at B. Riley Securities » 08:41
10/22/20
10/22
08:41
10/22/20
08:41
NVAX

Novavax

$91.25 /

-7.35 (-7.45%)

B. Riley Securities…

B. Riley Securities analyst Mayank Mamtani lowered the firm's price target on Novavax to $223 from $257 and reiterates a Buy rating on the shares. The company provided an incremental update on its COVID-19 vaccine candidate, NVX-CoV2373, at the 2020 World Vaccine Congress in advance of Phase II older subjects data disclosure anticipated imminently, Mamtani tells investors in a research note. Separately, the FDA released briefing documents ahead of the open session scheduled for October 22 for discussion on the development, authorization and licensure of C-19 vaccines, the analyst adds. The reduced price target reflects push out in U.S. market entry by one quarter and slightly reduced penetration given the "challenged national sentiment" towards vaccination, Mamtani writes.

ShowHide Related Items >><<
NVAX Novavax
$91.25 /

-7.35 (-7.45%)

NVAX Novavax
$91.25 /

-7.35 (-7.45%)

10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/25/20 Raymond James
Endo deal could generate $50M-$75M in cash inflow, says Raymond James
09/15/20 B. Riley Securities
Novavax deal with SIIPL doubles manufacturing capacity, says B. Riley FBR
09/09/20 B. Riley Securities
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
NVAX Novavax
$91.25 /

-7.35 (-7.45%)

NVAX Novavax
$91.25 /

-7.35 (-7.45%)

NVAX Novavax
$91.25 /

-7.35 (-7.45%)

NVAX Novavax
$91.25 /

-7.35 (-7.45%)

Wednesday
Hot Stocks
Colony Capital says DataBank made $30M investment in EdgePresence » 18:59
10/21/20
10/21
18:59
10/21/20
18:59
CLNY

Colony Capital

$3.19 /

+0.02 (+0.63%)

Colony Capital announced…

Colony Capital announced that DataBank has made a $30M strategic investment in EdgePresence, an owner and operator of multi-tenant, modular data centers, providing space, power, bandwidth, and interconnection across key U.S. markets. "Since 2018, EdgePresence has established an important strategic position at the 'far edge,'" said Doug Recker, Founder and President of EdgePresence. "By joining forces with DataBank, we'll act as a force multiplier for their edge data center strategy, helping to bring data centers closer to the data pools being created by users, enabling next-generation, data-localization strategies and applications for 5G and the IoT." EdgePresence will continue to be led by Recker and the existing management team, and will collaborate closely with DataBank's leadership team to expand its modular data center solutions.

ShowHide Related Items >><<
CLNY Colony Capital
$3.19 /

+0.02 (+0.63%)

CLNY Colony Capital
$3.19 /

+0.02 (+0.63%)

06/04/20 B. Riley Securities
Colony Capital price target lowered to $4 from $5 at B. Riley FBR
03/11/20 B. Riley Securities
B. Riley FBR downgrades CNO Financial, Progressive to Neutral from Buy
CLNY Colony Capital
$3.19 /

+0.02 (+0.63%)

CLNY Colony Capital
$3.19 /

+0.02 (+0.63%)

CLNY Colony Capital
$3.19 /

+0.02 (+0.63%)

Recommendations
Vail Resorts price target raised to $254 from $235 at Barclays » 06:31
10/21/20
10/21
06:31
10/21/20
06:31
MTN

Vail Resorts

$229.51 /

-1.36 (-0.59%)

Barclays analyst Felicia…

Barclays analyst Felicia Hendrix raised the firm's price target on Vail Resorts to $254 from $235 and reiterates an Overweight rating on the shares. The company's season pass program and geographically diverse mix of drive-to resorts "are both significant advantages in challenging times," Hendrix tells investors in a research note. The company's presence in the Northeast has been an important offset to destinations more vulnerable to COVID-19 related travel restrictions and limitations, says the analyst.

ShowHide Related Items >><<
MTN Vail Resorts
$229.51 /

-1.36 (-0.59%)

MTN Vail Resorts
$229.51 /

-1.36 (-0.59%)

09/25/20 Truist
Vail Resorts price target raised to $243 from $233 at Truist
09/25/20 Deutsche Bank
Vail Resorts price target raised to $218 from $204 at Deutsche Bank
09/11/20 Deutsche Bank
Vail Resorts price target raised to $204 from $174 at Deutsche Bank
08/31/20
Fly Intel: Top five analyst downgrades
MTN Vail Resorts
$229.51 /

-1.36 (-0.59%)

MTN Vail Resorts
$229.51 /

-1.36 (-0.59%)

MTN Vail Resorts
$229.51 /

-1.36 (-0.59%)

MTN Vail Resorts
$229.51 /

-1.36 (-0.59%)

Tuesday
Options
Novavax call volume above normal and directionally bullish » 12:45
10/20/20
10/20
12:45
10/20/20
12:45
NVAX

Novavax

$98.74 /

-3.27 (-3.21%)

Bullish option flow…

Bullish option flow detected in Novavax with 7,733 calls trading, 1.1x expected, and implied vol increasing almost 3 points to 106.87%. 11/27 weekly 70 calls and 10/23 weekly 90 puts are the most active options, with total volume in those strikes near 1,400 contracts. The Put/Call Ratio is 0.48. Earnings are expected on November 5th.

ShowHide Related Items >><<
NVAX Novavax
$98.74 /

-3.27 (-3.21%)

NVAX Novavax
$98.74 /

-3.27 (-3.21%)

10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/25/20 Raymond James
Endo deal could generate $50M-$75M in cash inflow, says Raymond James
09/15/20 B. Riley Securities
Novavax deal with SIIPL doubles manufacturing capacity, says B. Riley FBR
09/09/20 B. Riley Securities
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
NVAX Novavax
$98.74 /

-3.27 (-3.21%)

NVAX Novavax
$98.74 /

-3.27 (-3.21%)

NVAX Novavax
$98.74 /

-3.27 (-3.21%)

NVAX Novavax
$98.74 /

-3.27 (-3.21%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.